These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 15588972)
21. Does early rheumatoid arthritis exist? Dixon WG; Symmons DP Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):37-53. PubMed ID: 15588970 [TBL] [Abstract][Full Text] [Related]
22. Rheumatoid arthritis treatment and monitoring of outcomes--where are we [corrected] in 2007? Yazici Y; Abramson SB Bull NYU Hosp Jt Dis; 2007; 65(4):300-5. PubMed ID: 18081549 [TBL] [Abstract][Full Text] [Related]
23. Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice? Soubrier M; Zerkak D; Gossec L; Ayral X; Roux C; Dougados M J Rheumatol; 2006 Jul; 33(7):1243-6. PubMed ID: 16622906 [TBL] [Abstract][Full Text] [Related]
24. Early rheumatoid arthritis -- is there a window of opportunity? Cush JJ J Rheumatol Suppl; 2007 Nov; 80():1-7. PubMed ID: 17985417 [TBL] [Abstract][Full Text] [Related]
25. The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis. Haraoui B J Rheumatol Suppl; 2005 Jan; 72():46-7. PubMed ID: 15660467 [TBL] [Abstract][Full Text] [Related]
26. Physician ability to assess rheumatoid arthritis disease activity using an electronic medical record-based disease activity calculator. Collier DS; Grant RW; Estey G; Surrao D; Chueh HC; Kay J Arthritis Rheum; 2009 Apr; 61(4):495-500. PubMed ID: 19333984 [TBL] [Abstract][Full Text] [Related]
27. Established rheumatoid arthritis: clinical assessments. van Riel PL; Fransen J Best Pract Res Clin Rheumatol; 2007 Oct; 21(5):807-25. PubMed ID: 17870029 [TBL] [Abstract][Full Text] [Related]
28. The burden of rheumatoid arthritis and access to treatment: a medical overview. Smolen J; Aletaha D Eur J Health Econ; 2008 Jan; 8 Suppl 2():S39-47. PubMed ID: 18157733 [TBL] [Abstract][Full Text] [Related]
29. What are the goals and principles of management in the early treatment of rheumatoid arthritis? Bykerk VP; Keystone EC Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):147-61. PubMed ID: 15588976 [TBL] [Abstract][Full Text] [Related]
30. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria? El Miedany Y; Youssef SS; El Gaafary M J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918 [TBL] [Abstract][Full Text] [Related]
31. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis. Wolfe F; Rasker JJ; Boers M; Wells GA; Michaud K Arthritis Rheum; 2007 Aug; 57(6):935-42. PubMed ID: 17665487 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic strategies in early rheumatoid arthritis. Smolen JS; Aletaha D; Machold KP Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):163-77. PubMed ID: 15588977 [TBL] [Abstract][Full Text] [Related]
33. Quantitative target values of predictors of mortality in rheumatoid arthritis as possible goals for therapeutic interventions: an alternative approach to remission or ACR20 responses? Pincus T; Sokka T J Rheumatol; 2001 Jul; 28(7):1723-34. PubMed ID: 11469488 [TBL] [Abstract][Full Text] [Related]
34. Quantitative clinical rheumatology: "keep it simple, stupid": MDHAQ function, pain, global, and RAPID3 quantitative scores to improve and document the quality of rheumatologic care. Pincus T; Sokka T J Rheumatol; 2009 Jun; 36(6):1099-100. PubMed ID: 19509086 [No Abstract] [Full Text] [Related]
35. [Immunologic laboratory testing in clinical practice for rheumatoid arthritis]. Ota T Rinsho Byori; 2006 Aug; 54(8):861-8. PubMed ID: 16989407 [TBL] [Abstract][Full Text] [Related]
36. Imaging in early rheumatoid arthritis: roles of magnetic resonance imaging, ultrasonography, conventional radiography and computed tomography. Østergaard M; Ejbjerg B; Szkudlarek M Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):91-116. PubMed ID: 15588973 [TBL] [Abstract][Full Text] [Related]
37. Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritis. Wolfe F; Michaud K; Strand V J Rheumatol; 2005 Apr; 32(4):583-9. PubMed ID: 15801011 [TBL] [Abstract][Full Text] [Related]
38. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences. Fautrel B; Guillemin F; Meyer O; de Bandt M; Berthelot JM; Flipo RM; Lioté F; Maillefert JF; Wendling D; Saraux A; Combe B; Le Loët X; ; ; Arthritis Rheum; 2009 Apr; 61(4):425-34. PubMed ID: 19333993 [TBL] [Abstract][Full Text] [Related]
39. The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes. Wolfe F; Michaud K; Pincus T; Furst D; Keystone E Arthritis Rheum; 2005 Dec; 52(12):3873-9. PubMed ID: 16320335 [TBL] [Abstract][Full Text] [Related]
40. [Early referral and treatment of patients with acute arthritis. Experiences from two early arthritis clinics]. Lindegaard HM; Hørslev-Petersen K; Junker P Ugeskr Laeger; 2005 Nov; 167(47):4458-61. PubMed ID: 16305765 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]